Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-01-06 @ 8:05 AM
Study NCT ID:
NCT01767467
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2013-01-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-01
Start Date Type:
None
Primary Completion Date:
2016-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-10
First Submit QC Date:
None
Study First Post Date:
2013-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-05
Results First Submit QC Date:
None
Results First Post Date:
2017-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-31
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL